Actrapid and Solu-cortef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actrapid (insulin) and Solu-cortef (hydrocortisone sodium succinate). Common drug interactions include drug chemical incompatibility among females and coma among males.

The phase IV clinical study analyzes what interactions people have when they take Actrapid and Solu-cortef. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Actrapid?

Actrapid has active ingredients of insulin. eHealthMe is studying from 4,864 Actrapid users. Check the latest studies of Actrapid.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.



On Jul, 26, 2026

31 people who take Actrapid and Solu-cortef together, and have interactions are studied.

Actrapid and Solu-cortef drug interactions.

What are the common drug interactions of Actrapid and Solu-Cortef, by gender? *:

female:

  1. Drug chemical incompatibility
  2. Blood creatinine increased
  3. Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  6. Oesophageal candidiasis (fungal infection of oesophagus)
  7. Perinephric collection (fluid collections surrounding a kidney)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Renal transplant
  10. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)

male:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Drug effect prolonged
  3. Brain injury
  4. Dilatation ventricular
  5. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  6. Electrocardiogram t wave inversion
  7. Erythema (redness of the skin)
  8. Fatigue (feeling of tiredness)
  9. Pulmonary arterial pressure increased
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the common drug interactions of Actrapid and Solu-Cortef, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anastomotic leak
  2. Hyperkalaemia (damage to or disease of the kidney)
  3. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  4. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  5. Renal failure (kidney dysfunction)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Thrombocytopenia (decrease of platelets in blood)

30-39:

  1. Drug chemical incompatibility

40-49:

n/a

50-59:

  1. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  2. Torsade de pointes (a abnormal heart rate with abnormal beating pattern)
  3. Ventricular fibrillation (abnormally irregular heart rhythm)
  4. Acute myocardial infarction (acute heart attack)

60+:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Drug effect prolonged
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Renal transplant
  5. Urinary tract infection
  6. Wound dehiscence (a surgical incision reopens either internally or externally)
  7. Wound secretion
  8. Asthma
  9. Cardiac arrest
  10. Depressed level of consciousness

What are the existing conditions these people have? *

  1. Infection: 14 people, 45.16%
  2. Sedation: 11 people, 35.48%
  3. Asthma: 8 people, 25.81%
  4. Hyperglycemia (high blood sugar): 7 people, 22.58%
  5. Blood Glucose Abnormal: 7 people, 22.58%
  6. Hypersensitivity: 7 people, 22.58%
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 22.58%
  8. Metabolic Alkalosis (too much bicarbonate in the blood): 7 people, 22.58%
  9. Fungal Infection: 7 people, 22.58%
  10. Reversal Of Sedation: 7 people, 22.58%

* Approximation only. Some reports may have incomplete information.

Do you take Actrapid and Solu-cortef?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Actrapid and Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Actrapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actrapid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Solu-cortef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin and hydrocortisone sodium succinate (the active ingredients of Actrapid and Solu-cortef, respectively), and Actrapid and Solu-cortef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: